ETF Holdings Breakdown of IMCR

News associated with IMCR

Barclays PLC Buys 19,663 Shares of Immunocore Holdings plc (NASDAQ:IMCR)

Barclays PLC increased its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 2,044.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 20,625 shares of the company’s stock after purchasing an additional 19,663 shares during the quarter. Barclays PLC’s holdings in Immunocore were […] - 2025-05-08 07:36:44

Marshall Wace LLP Lowers Stock Holdings in Immunocore Holdings plc (NASDAQ:IMCR)

Marshall Wace LLP lessened its holdings in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 85.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 28,610 shares of the company’s stock after selling 170,833 shares during the quarter. Marshall Wace […] - 2025-05-01 08:43:01

Immunocore Holdings plc (NASDAQ:IMCR) Stake Boosted by Geode Capital Management LLC

Geode Capital Management LLC grew its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 1.2% during the 4th quarter, HoldingsChannel reports. The fund owned 35,492 shares of the company’s stock after acquiring an additional 420 shares during the period. Geode Capital Management LLC’s holdings in Immunocore were worth $1,047,000 as of […] - 2025-05-01 07:32:55

Renaissance Technologies LLC Sells 179,630 Shares of Immunocore Holdings plc (NASDAQ:IMCR)

Renaissance Technologies LLC decreased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 65.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 96,570 shares of the company’s stock after selling 179,630 shares during the period. Renaissance Technologies LLC owned […] - 2025-04-25 08:17:01

Brokerages Set Immunocore Holdings plc (NASDAQ:IMCR) Price Target at $63.73

Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have issued a buy recommendation on the company. […] - 2025-04-18 05:28:59

Immunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Orion Portfolio Solutions LLC

Orion Portfolio Solutions LLC lessened its position in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 37.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,017 shares of the company’s stock after selling 7,675 shares during the period. Orion Portfolio […] - 2025-04-09 08:02:51

Financial Contrast: Immunocore (NASDAQ:IMCR) vs. Creative Medical Technology (NASDAQ:CELZ)

Creative Medical Technology (NASDAQ:CELZ – Get Free Report) and Immunocore (NASDAQ:IMCR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Earnings and Valuation This table compares Creative […] - 2025-04-01 05:57:01

Immunocore Holdings plc (NASDAQ:IMCR) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have earned a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have given a buy recommendation to the […] - 2025-03-26 06:56:59

Principal Financial Group Inc. Sells 43,461 Shares of Immunocore Holdings plc (NASDAQ:IMCR)

Principal Financial Group Inc. reduced its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 8.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 502,857 shares of the company’s stock after selling 43,461 shares during the period. Principal Financial […] - 2025-02-27 09:06:54

Immunocore Holdings plc (NASDAQ:IMCR) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have received an average recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating […] - 2025-02-04 08:36:58

IMCR institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	18,574	USD 553,319
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	18,574	USD 553,319 -0.4%
Total =		37,148	USD 1,106,638

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer